NBSE insider filings

NeuBase Therapeutics, Inc. — 44 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-18. Screen NBSE transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for NBSE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — NeuBase Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-09-184Symetryx Corp — 10% ownerSale (S): 129,108 @ $1.44 · Sale (S): 103,337 @ $1.26 · Sale (S): 50,000 @ $1.19EDGAR
2023-09-114Symetryx Corp — 10% ownerSale (S): 74,852 @ $1.80 · Sale (S): 128,847 @ $1.53 · Sale (S): 3,376 @ $1.44EDGAR
2023-09-074Symetryx Corp — 10% ownerPurchase (P): 61,076 @ $0.98EDGAR
2023-08-044Stephan Dietrich A — Founder and CEO, Director, 10% ownerOption exercise (M): 93,234 @ $0.02 · Option exercise (M): 93,234 (derivative) @ $0EDGAR
2023-03-174Branning Todd P. — Chief Financial OfficerGrant/award (A): 54,200 @ $0EDGAR
2023-03-174Stephan Dietrich A — CEO and Director, Director, 10% ownerGrant/award (A): 153,000 @ $0EDGAR
2023-02-154Stephan Dietrich A — President and CEO, Director, 10% ownerOption exercise (M): 655,000 @ $0 · Option exercise (M): 655,000 (derivative) @ $0EDGAR
2022-11-044Branning Todd P. — Chief Financial OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2022-09-304Stephan Dietrich A — CEO, Director, 10% ownerOption exercise (M): 750,000 @ $0.00 · Option exercise (M): 750,000 (derivative) @ $0.00EDGAR
2022-09-124RICHMAN ERIC I — DirectorGrant/award (A): 37,600 (derivative) @ $0EDGAR
2022-09-124PRENDERGAST FRANKLYN G — DirectorGrant/award (A): 37,600 (derivative) @ $0EDGAR
2022-09-124McDougall Gerald J — DirectorGrant/award (A): 37,600 (derivative) @ $0EDGAR
2022-09-124Ende Eric J — DirectorGrant/award (A): 37,600 (derivative) @ $0EDGAR
2022-09-124GOLDSTEIN DOV A MD — DirectorGrant/award (A): 37,600 (derivative) @ $0EDGAR
2022-04-014Mann William Roland — Chief Operating OfficerPurchase (P): 6,200 @ $1.92EDGAR
2022-03-214Branning Todd P. — Chief Financial OfficerPurchase (P): 10,000 @ $1.81EDGAR
2022-03-184Branning Todd P. — Chief Financial OfficerPurchase (P): 10,000 @ $1.62 · Purchase (P): 10,000 @ $1.74EDGAR
2022-03-074RICHMAN ERIC I — DirectorPurchase (P): 1,580 @ $1.58 · Purchase (P): 1,300 @ $1.72 · Purchase (P): 1,000 @ $1.62EDGAR
2022-01-254Mann William Roland — Chief Operating OfficerGrant/award (A): 60,180 (derivative) @ $0EDGAR
2022-01-254Rojas-Caro Sandra — Chief Medical OfficerGrant/award (A): 44,592 (derivative) @ $0EDGAR
2022-01-254Stephan Dietrich A — President and CEO, Director, 10% ownerGrant/award (A): 306,000 (derivative) @ $0EDGAR
2022-01-104Branning Todd P. — Chief Financial OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-01-054Stephan Dietrich A — President and CEO, Director, 10% ownerOption exercise (M): 42,250 @ $0.00 · Option exercise (M): 42,250 (derivative) @ $0.00EDGAR
2022-01-054Ende Eric J — DirectorGrant/award (A): 165,803 (derivative) @ $0EDGAR
2021-09-244Mann William Roland — COOGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-09-174McDougall Gerald J — DirectorGrant/award (A): 38,135 (derivative) @ $0EDGAR
2021-09-174PRENDERGAST FRANKLYN G — DirectorGrant/award (A): 38,135 (derivative) @ $0EDGAR
2021-09-174RICHMAN ERIC I — DirectorGrant/award (A): 38,135 (derivative) @ $0EDGAR
2021-09-174GOLDSTEIN DOV A MD — DirectorGrant/award (A): 38,135 (derivative) @ $0EDGAR
2021-06-214GOLDSTEIN DOV A MD — DirectorPurchase (P): 8,000 @ $4.75EDGAR
2021-05-254Rojas-Caro Sandra — Chief Medical OfficerGrant/award (A): 280,000 (derivative) @ $0EDGAR
2021-05-254Motesharei Kianoush — See RemarksGrant/award (A): 250,000 (derivative) @ $0EDGAR
2021-05-134McDougall Gerald J — DirectorGrant/award (A): 92,219 (derivative) @ $0EDGAR
2021-04-274RICHMAN ERIC I — DirectorPurchase (P): 5,000 @ $5EDGAR
2021-04-274Stephan Dietrich A — President and CEO, Director, 10% ownerPurchase (P): 12,000 @ $5EDGAR
2021-04-274Mann William Roland — COOPurchase (P): 5,000 @ $5EDGAR
2021-04-274GOLDSTEIN DOV A MD — DirectorPurchase (P): 12,000 @ $5EDGAR
2020-12-304Stephan Dietrich A — President and CEO, Director, 10% ownerGift (G): 2,547,639 @ $0 · Gift (G): 1,273,819 @ $0 · Gift (G): 1,273,819 @ $0 · Gift (G): 1,273,820 @ $0 · Grant/award (A): 164,925 (derivative) @ $0EDGAR
2020-12-304Backenroth Samuel — CFO, Treasurer & SecretaryGrant/award (A): 41,915 (derivative) @ $0EDGAR
2020-12-024Bradshaw Curt — Chief Scientific OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2020-09-114Miralles Gines Diego — DirectorGrant/award (A): 14,634 (derivative) @ $0EDGAR
2020-09-114RICHMAN ERIC I — DirectorGrant/award (A): 14,634 (derivative) @ $0EDGAR
2020-09-114PRENDERGAST FRANKLYN G — DirectorGrant/award (A): 14,634 (derivative) @ $0EDGAR
2020-09-114GOLDSTEIN DOV A MD — DirectorGrant/award (A): 14,634 (derivative) @ $0EDGAR

Recent 8-K events — NeuBase Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-01-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-06-278-K3.03 — Material Modification to Rights of Security Holders
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-318-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-228-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-138-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-038-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-058-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-268-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NBSE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs